Last reviewed · How we verify
Ropivacaine nebulization
Ropivacaine is a local anesthetic that works by blocking sodium channels in nerve fibers, preventing the initiation and transmission of nerve impulses.
Ropivacaine is a local anesthetic that works by blocking sodium channels in nerve fibers, preventing the initiation and transmission of nerve impulses. Used for Regional anesthesia for surgical procedures, Pain management for postoperative patients.
At a glance
| Generic name | Ropivacaine nebulization |
|---|---|
| Also known as | Ropivacaine, Nebulization |
| Sponsor | San Gerardo Hospital |
| Drug class | Local anesthetic |
| Target | Voltage-gated sodium channels |
| Modality | Small molecule |
| Therapeutic area | Anesthesiology |
| Phase | Phase 3 |
Mechanism of action
This action results in a temporary loss of sensation and motor function in the affected area. Ropivacaine has a slower onset and longer duration of action compared to other local anesthetics, making it suitable for prolonged procedures.
Approved indications
- Regional anesthesia for surgical procedures
- Pain management for postoperative patients
Common side effects
- Nausea
- Vomiting
- Dizziness
- Headache
- Tachycardia
Key clinical trials
- Comparison of SPSIP Block and SAP Block in Non-Intubated Uniportal VATS. (NA)
- Nebulized Analgesia for Laparoscopic Appendectomy Trial (PHASE1, PHASE2)
- Intraperitoneal Ropivacaine Nebulization for Pain Control After Gynecologic Laparoscopic Surgery (PHASE3)
- Peritoneal Nebulization of Ropivacaine for Pain Control After Laparoscopic Colectomy (PHASE3)
- Impact of Intraperitonael Nebulization of Local Anesthetic on Postoperative Pain Associated With Laparoscopic Surgery (PHASE3)
- Pain Relief by Intra-Peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia for Gynecological Laparoscopy (PHASE3)
- Intraperitoneal Ropivacaine Nebulization for Pain Control After Laparoscopic Surgery (PHASE3)
- Local Anesthetic Nebulization and Instillation for Pain Control After Laparoscopic Surgery (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ropivacaine nebulization CI brief — competitive landscape report
- Ropivacaine nebulization updates RSS · CI watch RSS
- San Gerardo Hospital portfolio CI